Steven Cohen’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
Steven Cohen's OCUL Position: Q3 2026 in Review
Steven Cohen reduced its Ocular Therapeutix (OCUL) stake by 91% in Q3 2026, selling an estimated $29.4M and leaving 283,555 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2367.
Steven Cohen first reported a position in OCUL in Q2 2022 and has held it in 12 quarters since. The position peaked at $53.8M in Q3 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- Steven Cohen held 283,555 shares of Ocular Therapeutix worth $2.17M as of Q3 2026.
- Steven Cohen sold 3,008,638 Ocular Therapeutix shares in Q3 2026, an estimated $29.4M.
- Ocular Therapeutix made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2367 holding.
- Steven Cohen first reported a position in Ocular Therapeutix in Q2 2022 and has held it in 12 quarters since.
- Steven Cohen's Ocular Therapeutix position peaked at $53.8M in Q3 2025.
- 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.